Taking cues, manufacturers are getting into mergers and acquisitions to launch products that aid bone formation during surgeries. Bone growth stimulator, once implanted at the time of spinal fusion surgery, generates a weak electrical current to target the desired spot with electromagnet fields to speed up the healing process. The popularity of minimally invasive surgeries is linked with a set of advantages such as smaller incisions, negligent scarring, minimised amount of blood loss, and much more. According to the World Health Organization, globally, around 250,000 to 500,000 people suffer from spinal cord injuries annually, mainly because of road accidents, falls, and violence. To add to this, the prevalence of spinal cord injuries globally has led to increased demand for spinal fusion surgeries. The escalating demand for minimally invasive or non-invasive surgeries to treat patients with bone injuries is boosting the demand for bone growth stimulators. Non-invasive or minimally invasive surgeries fuelling demand for bone growth stimulators In this blog, we will discuss how the use of bone growth stimulators is accelerating the healing of bone-related injuries such as fractures. As per studies, during the Covid-19 pandemic, in 2020, the elderly population became more prone to bone fractures due to lack of out-of-home activities, sedentary lifestyle, decreased exposure to sunlight, and consequent Vitamin D deficiency.Ĭonsidering the aforementioned factors, the spotlight is on bone growth stimulators and their highly efficient properties.

The technology behind a bone growth stimulator is helpful for people more prone to internal injuries and fractures as a result of accidents.

Bone growth stimulation therapy has gained immense popularity in the past few years across the global healthcare sector. The best part about a bone growth stimulator is that it accelerates the whole process of bone healing which leads to a speedy recovery, reduced time of patient stay, increased cost-effectiveness, and lessens the chances of infections.ĮSOMAR-certified market intelligence firm, Future Market Insights, projects the global market for bone growth stimulators to US$ 1.8 Bn by the end of 2022, exhibiting a CAGR of 9.9% through 2028. With the advent of technology, the healthcare sector has witnessed numerous changes including the introduction of bone growth stimulators.

Orthofix bone stimulator